Orforglipron (hemicalcium hydrate)
Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185) . Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete[1].
Product Specifications
CAS Number
[3008544-96-2]
Product Name Alternative
LY3502970 (hemicalcium hydrate) ; GLP-1 receptor agonist 1 (hemicalcium hydrate)
UNSPSC
12352005
Target
GCGR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/orforglipron-hemicalcium-hydrate.html
Purity
99.71
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
Molecular Formula
C48H48F2N10O5.1/2Ca.H2O
Molecular Weight
921.02
References & Citations
[1]Pyrazolopyridine derivative having glp-1 receptor agonist effect. WO2018056453A1
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items